Updating results

1526 results

Sort: Relevance | Date

Safe prescribing and withdrawal management of prescribed drugs associated with dependence and withdrawal

In development [GID-NG10141] Expected publication date: 17 November 2021

NICE guideline In development

Children and young people with disabilities & severe complex needs: integrated health & social care support & service guidance

In development [GID-NG10113] Expected publication date: 12 May 2021

NICE guideline In development

Pelvic floor dysfunction: prevention and non-surgical management

In development [GID-NG10123] Expected publication date: 26 August 2021

NICE guideline In development

Healthcare-associated infections: prevention and control: surveillance consultation

We are listening to your views on this NICE guideline. Comments close 20 September 2019.

Public health guideline In consultation

Preterm labour and birth (update)

In development [GID-NG10078] Expected publication date: 02 August 2019

NICE guideline In development

Impetigo: antimicrobial prescribing

In development [GID-NG10134] Expected publication date: 14 February 2020

Antimicrobial prescribing guideline In development

Neonatal parenteral nutrition: draft guidance consultation

We are listening to your views on this NICE guideline. Comments close 18 October 2019.

NICE guideline In consultation

Postnatal care

In development [GID-NG10070] Expected publication date: 25 November 2020

NICE guideline In development

Diverticular disease: diagnosis and management

In development [GID-NG10064] Expected publication date: 27 November 2019

NICE guideline In development

Termination of pregnancy

In development [GID-NG10058] Expected publication date: 25 September 2019

NICE guideline In development

Joint replacement (primary): hip, knee and shoulder

In development [GID-NG10084] Expected publication date: 25 March 2020

NICE guideline In development

Looked-after children and young people

In development [GID-NG10121] Expected publication date: 26 April 2021

NICE guideline In development

Mental wellbeing at work

In development [GID-NG10140] Expected publication date: 18 August 2021

NICE guideline In development

Neonatal infection (early onset): antibiotics for prevention and treatment

In development [GID-NG10111] Expected publication date: 05 March 2021

NICE guideline In development

Rehabilitation in adults with complex psychosis and related severe mental health conditions

In development [GID-NG10092] Expected publication date: 19 June 2020

NICE guideline In development

Social, emotional and mental wellbeing in primary and secondary education

In development [GID-NG10125] Expected publication date: 28 May 2021

NICE guideline In development

Vaccine uptake in the general population

In development [GID-NG10139] Expected publication date: 19 October 2021

NICE guideline In development

Workplace health: long-term sickness absence and capability to work (Update)

In development [GID-NG10090] Expected publication date: 20 November 2019

NICE guideline In development

Social work interventions for adults with complex needs, including, learning disabilities and mental health

In development [GID-NG10145] Expected publication date: 19 January 2022

NICE guideline In development

Colorectal cancer: diagnosis and management (update)

In development [GID-NG10060] Expected publication date: 29 January 2020

NICE guideline In development

Caesarean section (Update)

In development [GID-NG10081] Expected publication date: 10 November 2020

NICE guideline In development

Inducing labour (Update)

In development [GID-NG10082] Expected publication date: 01 July 2020

NICE guideline In development

Carers: provision of support for adult carers

In development [GID-NG10046] Expected publication date: 22 January 2020

NICE guideline In development

Behaviour change: digital and mobile health interventions

In development [GID-NG10101] Expected publication date: 05 August 2020

NICE guideline In development

Skin tumours including Melanoma: assessment and management

In development [GID-NG10155] Expected publication date: 28 March 2022

NICE guideline In development

Diabetes update

In development [GID-NG10152] Expected publication date: TBC

NICE guideline In development

Safeguarding adults in care homes

In development [GID-NG10107] Expected publication date: 21 October 2020

NICE guideline In development

Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management

In development [GID-NG10091] Expected publication date: 14 October 2020

NICE guideline In development

Asthma: diagnosis, monitoring and chronic asthma management

In development [GID-NG10143] Expected publication date: 29 January 2020

NICE guideline In development

Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management: call for evidence

We are listening to your views on this NICE guideline. Comments close 16 October 2019.

NICE guideline In consultation

Fever in under 5s: assessment and initial management: draft guidance consultation

We are listening to your views on this NICE guideline. Comments close 19 September 2019.

NICE guideline In consultation

Meningitis (bacterial) and meningococcal septicaemia: recognition, diagnosis and management

In development [GID-NG10149] Expected publication date: 17 February 2022

NICE guideline In development

Multiple sclerosis in adults: management

In development [GID-NG10153] Expected publication date: 27 April 2022

NICE guideline In development

Babies, children and young people's experience of healthcare

In development [GID-NG10119] Expected publication date: 07 April 2021

NICE guideline In development

Shared decision making

In development [GID-NG10120] Expected publication date: 14 April 2021

NICE guideline In development

Acute coronary syndromes

In development [GID-NG10085] Expected publication date: 25 June 2020

NICE guideline In development

Reducing sexually transmitted infections

In development [GID-NG10142] Expected publication date: 01 September 2021

NICE guideline In development

Violence and aggression: short-term management in mental health, health and community settings: surveillance consultation

We are listening to your views on this NICE guideline. Comments close 02 October 2019.

NICE guideline In consultation

Self-harm in over 8s: short- and long-term management and prevention of recurrence

In development [GID-NG10148] Expected publication date: 26 January 2022

NICE guideline In development

Depression in adults: treatment and management

In development [GID-CGWAVE0725] Expected publication date: TBC

NICE guideline In development

Cabozantinib for previously treated advanced hepatocellular carcinoma (terminated appraisal) (TA582)

NICE is unable to make a recommendation about the use in the NHS of cabozantinib (Cometriq) for previously treated advanced hepatocellular carcinoma in adults

Technology appraisal guidance Published May 2019

Padeliporfin for untreated localised prostate cancer (TA546)

Evidence-based recommendations on padeliporfin (Tookad) for untreated, unilateral, low-risk prostate cancer in adults

Technology appraisal guidance Published November 2018

Sofosbuvir–velpatasvir–voxilaprevir for treating chronic hepatitis C (TA507)

Evidence-based recommendations on sofosbuvir–velpatasvir–voxilaprevir (Vosevi) for treating chronic hepatitis C (HCV) in adults

Technology appraisal guidance Published February 2018

Intrabeam radiotherapy system for adjuvant treatment of early breast cancer (TA501)

Evidence-based recommendations on using Intrabeam radiotherapy during breast-conserving surgery for adults with early breast cancer

Technology appraisal guidance Published January 2018

Denosumab for preventing skeletal-related events in multiple myeloma (terminated appraisal) (TA549)

NICE is unable to make a recommendation about the use in the NHS of denosumab for preventing skeletal-related events in multiple myeloma because no evidence

Technology appraisal guidance Published December 2018

Decitabine for untreated acute myeloid leukaemia (terminated appraisal) (TA548)

NICE is unable to make a recommendation about the use in the NHS of decitabine for untreated acute myeloid leukaemia because no evidence submission was

Technology appraisal guidance Published December 2018

Ocrelizumab for treating relapsing–remitting multiple sclerosis (TA533)

Evidence-based recommendations on ocrelizumab (Ocrevus) for treating relapsing–remitting multiple sclerosis (MS) in adults

Technology appraisal guidance Published July 2018

Lutetium (177Lu) oxodotreotide for treating unresectable or metastatic neuroendocrine tumours (TA539)

Evidence-based recommendations on lutetium (177Lu) oxodotreotide (Lutathera) for treating unresectable or metastatic neuroendocrine tumours in adults

Technology appraisal guidance Published August 2018

Bosutinib for untreated chronic myeloid leukaemia (terminated appraisal) (TA576)

NICE is unable to make a recommendation about the use in the NHS of bosutinib for untreated chronic myeloid leukaemia because no evidence submission was

Technology appraisal guidance Published April 2019

Dabrafenib with trametinib for treating advanced metastatic BRAF V600E mutation-positive non-small-cell lung cancer (terminated appraisal) (TA564)

NICE is unable to make a recommendation about the use in the NHS of dabrafenib with trametinib for treating advanced metastatic BRAF V600E mutation-positive

Technology appraisal guidance Published February 2019